FEBRUARY, 2012 Gene-Related Patents Issued - Full patent | ||||
CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,114,639 | Method for producing an L-amino acid using a bacterium of the enterobacteriaceae family with attenuated expression of the sfmACDFH-fimZ cluster or the fimZ gene | Ajinomoto Co., Inc. | 14-Feb-12 | Japan |
8,114,649 | L-cysteine producing microorganism and a method for producing L-cysteine | Ajinomoto Co., Inc. | 14-Feb-12 | Japan |
8,114,632 | Method of producing biologically active polypeptide having insulinotropic activity | Biocon Limited | 14-Feb-12 | India |
8,124,351 | Quantification of fusion proteins and their activity from chromosomal translocation | Board of Regents, The University of Texas System | 28-Feb-12 | United States |
8,119,351 | CC2D2A gene mutations associated with Joubert syndrome and diagnostic methods for identifying the same | Centre for Addiction and Mental Health | 21-Feb-12 | Canada |
8,114,650 | Nucleic acid and its use effecting ciliate tetrahymena bifunctional dihydrofolate reductase-thymidylate synthase deficiency | Cilian AG | 14-Feb-12 | Germany |
8,124,369 | Method of cleaving DNA with rationally-designed meganucleases | Duke University | 28-Feb-12 | United States |
8,119,361 | Methods of cleaving DNA with rationally-designed meganucleases | Duke University | 21-Feb-12 | United States |
8,119,381 | Rationally-designed meganucleases with altered sequence specificity and DNA-binding affinity | Duke University | 21-Feb-12 | United States |
8,114,597 | Method of profiling gene expression in a subject undergoing a treatment | GeneNews Corporation | 14-Feb-12 | United States |
8,110,358 | Method of profiling gene expression in a subject having prostate cancer | GeneNews Corporation | 7-Feb-12 | United States |
8,114,624 | Use of the ornithine transcarbamylase (OTC), as a marker for diagnosing brain damages | Genoscreen | 14-Feb-12 | France |
8,110,363 | Expression profiles to predict relapse of prostate cancer | Illumina, Inc. | 7-Feb-12 | United States |
8,114,596 | Producing, cataloging and classifying sequence tags | Kaufman; Joseph C. | 14-Feb-12 | United States |
RE43,166 | Gene encoding chondroitinase ABC and uses therefor | Maruha Nichiro Foods, Inc. | 7-Feb-12 | Japan |
8,119,377 | Recombinant microorganisms for increased production of organic acids | Michigan Biotechnology Institute | 21-Feb-12 | United States |
8,110,362 | Method for determining a tongue cancer | Niigata University | 7-Feb-12 | Japan |
8,124,341 | Genes and polypeptides relating to hepatocellular or colorectal carcinoma | Oncotherapy Science, Inc. | 28-Feb-12 | Japan |
8,124,345 | Cystic fibrosis transmembrane conductance regulator gene mutations | Quest Diagnostics Investments Incorporated | 28-Feb-12 | United States |
8,114,583 | Switch-region: target and method for inhibition of bacterial RNA polymerase | Rutgers, The State University of New Jersey | 14-Feb-12 | United States |
8,114,620 | Diagnostic and therapeutic target PRKX proteins for neurodegenerative diseases | Takeda Pharmaceutical Company Limited | 14-Feb-12 | Japan |
8,119,340 | Methods and compositions for diagnosis and treatment of B cell chronic lymphocytic leukemia | The Feinstein Institute for Medical Research | 21-Feb-12 | United States |
8,119,341 | Genetic variant of the annexin A5 gene | Universitaesklinikum Muenster | 21-Feb-12 | Germany |
8,114,593 | Cancer biomarker genes and gene products and methods for using the same | University of Medicine and Dentistry of New Jersey | 14-Feb-12 | United States |
DATA PROCESSING | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,112,230 | Method of network-based identification of multicomponent synergy and compositions for use as effective component of anti-angiogenesis medicines | Tsinghua University | 7-Feb-12 | China P. Rep. |
DRUG | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,114,851 | Method and medicament for inhibiting the expression of a given gene | Alnylam Pharmaceuticals, Inc. | 14-Feb-12 | United States |
8,119,590 | Prevention and treatment of restenosis by local administration of drug | Cedars-Sinai Medical Center | 21-Feb-12 | United States |
8,110,187 | Purification and characterization of cytotoxic lymphocyte maturation factor and monoclonal antibodies thereto | Hoffman-La Roche Inc. | 7-Feb-12 | United States |
8,124,093 | Human cytomegalovirus neutralizing antibodies and use thereof | Institute for Research in Biomedicine | 28-Feb-12 | Switzerland |
8,119,146 | Expressing hepatitis B virus surface antigen for vaccine preparation | Medina-Selby; Angelica | 21-Feb-12 | United States |
8,119,136 | Methods of modulating apoptosis by administration of relaxin agonists or antagonists | Molecular Medicine Research Institute | 21-Feb-12 | United States |
8,124,101 | Genetically engineered swine influenza virus and uses thereof | Mount Sinai School of Medicine | 28-Feb-12 | United States |
8,110,183 | Method for sustained expression of an exogenous gene | National Tsing Hua University | 7-Feb-12 | Taiwan |
8,114,401 | Chlamydia trachomatis antigens | Ratti; Giulio | 14-Feb-12 | Italy |
8,114,395 | Treatment of viral diseases with recombinant interferon .alpha. | Sichuan Biotechnology Research Center | 14-Feb-12 | China P. Rep. |
8,110,560 | Spinal muscular atrophy (SMA) treatment via targeting of SMN2 splice site inhibitory sequences | University of Massachusetts | 7-Feb-12 | United States |
8,110,556 | Method of expressing human lysosomal protein in brain cells | University of Medicine and Dentistry of New Jersey | 7-Feb-12 | United States |
8,119,589 | Modulation of CD4.sup.+ T cell responses by a tick saliva protein, Salp15 and polypeptides derived therefrom | University of North Carolina at Charlotte | 21-Feb-12 | United States |
MULTICELLULAR LIVING ORGANISMS | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,115,087 | Wheat with altered branching enzyme activity and starch and starch containing products derived therefrom | Commonwealth Scientific and Industrial Research Organisation | 14-Feb-12 | Australia |
8,124,843 | Methods and genetic compositions to limit outcrossing and undesired gene flow in crop plants | Dow AgroSciences LLC | 28-Feb-12 | United States |
8,124,831 | Transgenic mice carrying functional single nucleotide polymorphisms in brain-specific tryptophan hydroxylase | Duke University | 28-Feb-12 | United States |
8,115,055 | Down-regulation of gene expression using artificial microRNAs | E.I. du Pont de Nemours and Company | 14-Feb-12 | United States |
8,119,855 | Resistance to abiotic stress in plants | Expressive Research B.V. | 28-Feb-12 | Netherlands |
8,110,722 | Aromatic acyltransferase genes | Local Independent Administrative Institution Aomori Prefectural Industrial Technology Research Center | 7-Feb-12 | Japan |
8,124,835 | Acyl-coa-dependent diacylglycerol acyltransferas 1 (DGAT1) gene from Tropaeolum majus, protein encoded thereby and uses thereof | National Research Council of Canada | 28-Feb-12 | Canada |
8,110,719 | ABI1 conditional knockout mouse | New York Blood Center, Inc. | 7-Feb-12 | United States |
8,124,834 | Use of active cytokinin synthase gene | Riken | 28-Feb-12 | Japan |
8,115,058 | Rice promoters for regulation of plant expression | Syngenta Participations AG | 14-Feb-12 | Switzerland |
8,124,837 | Engineering resistance to Pierce's disease by expression of a Xyella fastidiosa HecA-like hemagglutinin protein | The Regents of the University of California | 28-Feb-12 | United States |
8,115,059 | Gene expression modulation system for use in plants and method for modulating gene expression in plants | University of Kentucky Research Foundation | 14-Feb-12 | United States |
NATURAL RESINS OR DERIVATIVES | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,124,741 | Antibodies to tumor associated proteins | Agensys, Inc. | 28-Feb-12 | United States |
8,110,662 | Antibody directed to protein involved in maintaining differentiation of smooth muscle cells | Chugai Seiyaku Kabushiki Kaisha | 7-Feb-12 | Japan |
8,124,728 | CA125 gene and its use for diagnostic and therapeutic interventions | The Board of Trustees of the University of Arkansas | 28-Feb-12 | United States |
ORGANIC COMPOUNDS | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,114,982 | Multi-microRNA methods and compositions | Albert Einstein College of Medicine of Yeshiva University | 14-Feb-12 | United States |
8,119,608 | Method and medicament for inhibiting the expression of a given gene | Alnylam Pharmaceuticals, Inc. | 21-Feb-12 | United States |
8,114,984 | RNAi modulation of Aha and therapeutic uses thereof | Alnylam Pharmaceuticals, Inc. | 14-Feb-12 | United States |
8,114,981 | Method and medicament for inhibiting the expression of a given gene | Alnylam Pharmaceuticals, Inc. | 14-Feb-12 | United States |
8,124,752 | Compositions and methods for inhibiting expression of the MYC gene | Alnylam Pharmaceuticals, Inc. | 28-Feb-12 | United States |
8,124,748 | Cell surface glycoprotein | Ares Trading S.A. | 28-Feb-12 | Switzerland |
8,119,785 | Nucleic acid sequences and homologous recombination vectors for distruption of a Fel D I gene | Avner; David B. | 21-Feb-12 | United States |
8,119,791 | si-RNA-mediated gene silencing technology to inhibit tyrosinase and reduce pigmentation | Avon Products, Inc. | 21-Feb-12 | United States |
8,110,668 | Sperm-specific cation channel, catsper-3 and uses therefor | Children's Medical Center Corporation | 7-Feb-12 | United States |
8,110,672 | Promoter engineering and genetic control | Massachusetts Institute of Technology | 7-Feb-12 | United States |
8,124,755 | hTERT gene expression regulatory gene | National University Corporation Tottori University | 28-Feb-12 | Japan |
8,119,610 | Method for efficient RNA interference in mammalian cells | The Regents of the University of California | 21-Feb-12 | United States |
8,124,753 | Compositions and methods for inhibiting translation of a Mect1-MAML2 chimeric gene | The United States of America as represented by the Department of Health and Human Services | 28-Feb-12 | United States |
8,114,976 | Cryptosporidium hominis genes and gene products for chemotherapeutic, immunoprophylactic and diagnostic applications | Virginia Commonwealth University | 14-Feb-12 | United States |
Login
Advertisements
Eden's Bounty Multi-SanTM
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
TERRA+ CLEAN Acid-Replacement Surface Cleaner
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.